49 related articles for article (PubMed ID: 38459910)
21. Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Sands BE; D'Haens G; Clemow DB; Irving PM; Johns JT; Hunter Gibble T; Abreu MT; Lee S; Hisamatsu T; Kobayashi T; Dubinsky MC; Vermeire S; Siegel CA; Peyrin-Biroulet L; Moses RE; Milata J; Arora V; Panaccione R; Dignass A
Inflamm Bowel Dis; 2024 Mar; ():. PubMed ID: 38459910
[TBL] [Abstract][Full Text] [Related]
22. Mirikizumab: A New Therapeutic Option for the Treatment of Ulcerative Colitis.
Choi D; Sheridan H; Bhat S
Ann Pharmacother; 2024 Feb; ():10600280241229742. PubMed ID: 38344998
[TBL] [Abstract][Full Text] [Related]
23. Etrolizumab for induction of remission in ulcerative colitis.
Rosenfeld G; Parker CE; MacDonald JK; Bressler B
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011661. PubMed ID: 26630451
[TBL] [Abstract][Full Text] [Related]
24. Vedolizumab for induction and maintenance of remission in ulcerative colitis.
Bickston SJ; Behm BW; Tsoulis DJ; Cheng J; MacDonald JK; Khanna R; Feagan BG
Cochrane Database Syst Rev; 2014 Aug; (8):CD007571. PubMed ID: 25105240
[TBL] [Abstract][Full Text] [Related]
25. Mirikizumab for the treatment of moderate to severe ulcerative colitis.
Hanzel J; Ma C; Jairath V
Immunotherapy; 2023 Oct; 15(15):1199-1208. PubMed ID: 37465925
[TBL] [Abstract][Full Text] [Related]
26. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
27. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
[TBL] [Abstract][Full Text] [Related]
28. Oral budesonide for induction of remission in ulcerative colitis.
Sherlock ME; MacDonald JK; Griffiths AM; Steinhart AH; Seow CH
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD007698. PubMed ID: 26497719
[TBL] [Abstract][Full Text] [Related]
29. Helminth therapy (worms) for induction of remission in inflammatory bowel disease.
Garg SK; Croft AM; Bager P
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009400. PubMed ID: 24442917
[TBL] [Abstract][Full Text] [Related]
30. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
Chande N; Wang Y; McDonald JW; MacDonald JK
Cochrane Database Syst Rev; 2015 Aug; 8(8):CD006774. PubMed ID: 35658167
[TBL] [Abstract][Full Text] [Related]
31. Mirikizumab: First Approval.
Keam SJ
Drugs; 2023 Jul; 83(11):1045-1052. PubMed ID: 37389706
[TBL] [Abstract][Full Text] [Related]
32. Ozanimod: A Review in Ulcerative Colitis.
Paik J
Drugs; 2022 Aug; 82(12):1303-1313. PubMed ID: 35994200
[TBL] [Abstract][Full Text] [Related]
33. Type I interferons for induction of remission in ulcerative colitis.
Wang Y; MacDonald JK; Benchimol EI; Griffiths AM; Steinhart AH; Panaccione R; Seow CH
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD006790. PubMed ID: 26368001
[TBL] [Abstract][Full Text] [Related]
34. Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
Cochrane Database Syst Rev; 2012 Nov; 11():CD004118. PubMed ID: 23152224
[TBL] [Abstract][Full Text] [Related]
35. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Pandit NG; Zaman M; Minkoff NZ; Tanner-Smith EE; Gomez-Duarte OG; Acra S; Nicholson MR
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD012774. PubMed ID: 37094824
[TBL] [Abstract][Full Text] [Related]
36. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
[TBL] [Abstract][Full Text] [Related]
37. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Wang Y; Parker CE; Feagan BG; MacDonald JK
Cochrane Database Syst Rev; 2016 May; 2016(5):CD000544. PubMed ID: 27158764
[TBL] [Abstract][Full Text] [Related]
38. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.
Lawson MM; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2006 Jul; (3):CD005112. PubMed ID: 16856078
[TBL] [Abstract][Full Text] [Related]
39. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Timmer A; McDonald JW; Tsoulis DJ; Macdonald JK
Cochrane Database Syst Rev; 2012 Sep; (9):CD000478. PubMed ID: 22972046
[TBL] [Abstract][Full Text] [Related]
40. Tacrolimus (FK506) for induction of remission in corticosteroid-refractory ulcerative colitis.
Gordon M; Sinopoulou V; Akobeng AK; Pana M; Gasiea R; Moran GW
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD007216. PubMed ID: 35388476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
